A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.
Clinical trial NCT02164955 · COMPLETED
Trial details
- NCT number
- NCT02164955
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-06-26
- Primary completion
- 2022-10-10
- Enrollment
- 775
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.